Cyclin B1 overexpression and/or mislocalization has been described in several primary cancers including breast, colon, gastric, prostate, thyroid carcinoma and non small-cell lung cancer (NSCLC) [139,140,141,142,143]. This evidence concerns the gene CCNB1 and non-small cell lung carcinoma.